Making the Best Decision for Your Child
COVID-19 Vaccine Information
The Pfizer vaccine has been authorized for children aged 5-11 under an emergency use authorization (granted when a drug is needed for emergency use.) by the Food and Drug Administration. Through established data we know that the COVID vaccine provides many benefits and is our way to end the COVID pandemic.
The vaccine can:
- Protect your child from severe COVID-19 and potential hospitalization.
- Protect family members and friends by stopping the spread of the virus.
- Keep them in school and return to traditional sports and other extracurricular activities.
- Move toward elimination of mask-wearing requirements.
- Reduce the spread of the virus within the community.
COVID-19 Vaccine for Kids: Everything You Need to Know
Now that the COVID-19 vaccine is authorized for children 5-11 years old, it might be time to have a conversation with your kids about what the vaccine is, how getting it could make them feel, and why it’s important. Here are a few tips for having that conversation.
Click here for even more blog content about the COVID-19 vaccine and kids.
Dr. Dave Stukus has an important message for parents.
Click here for even more video content about the COVID-19 vaccine and kids.
Currently, only the COVID-19 Pfizer vaccine is now authorized for use in children 5 to 11 years old. We answer parents' questions about vaccinating their kids.
COVID-19 Vaccine: Where to Go
Nationwide Children’s offers the COVID-19 vaccine at our main campus location. Click here to schedule an appointment.
However, the vaccine is being offered at many locations throughout Columbus, including:
In collaboration with Columbus Public Health, Nationwide Children’s Hospital is partnering with some Central Ohio schools to administer the Pfizer COVID-19 vaccine to children five and older. Please call (614) 355-2590 (Option 3) for locations and times. Click here to learn more about school-based health services.
Third Dose Vaccine
According to the FDA and the CDC, a third dose of the mRNA COVID-19 vaccine (Pfizer or Moderna, depending on age) can be administered to immunocompromised individuals following completion of the two-dose COVID-19 vaccine series.
Who is eligible for a third dose of the COVID-19 vaccine?
The third dose is recommended at least 28 days after completion of the second dose for qualifying immunocompromised people age five+ who received the Pfizer series and people age 18+ who received either the Janssen or Moderna series.
Nationwide Children’s provides Pfizer and Moderna vaccine booster doses in response to approval by the US Food and Drug Administration (FDA) and the US Centers for Disease Control and Prevention (CDC).
The Booster is recommended for all vaccine recipients 12 years of age and older:
- Recipients 12 years old or older, and have received the second dose of the Pfizer series at least five months prior
- Recipients 18 years old or older, and have received the second dose of the Moderna series at least five months prior
- Recipients 18 years old or older, and have received the second dose of the Janssen at least two months prior
Vaccines may be the same or different (Pfizer, Moderna or Janssen) than the primary series for booster for adults 18+, based on availability and preference. Adolescents 12-17 will be offered the Pfizer vaccine as it is the only vaccine authorized or approved in this age group. Nationwide Children's is currently offering the Pfizer and Moderna vaccines.
Additional information on booster doses is available from the CDC here.
Booster vaccines can be scheduled here.